Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lymphoma, Large B-Cell, Diffuse × Drug Therapy × Clear all

Phase

Status

Completed 6 Recruiting 2 Withdrawn 1 Unknown 1 Terminated 1 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Stomach Neoplasms 22 Colorectal Neoplasms 20 Breast Neoplasms 19 Neoplasms 16 Esophageal Squamous Cell Carcinoma 12 Neoplasm Metastasis 11 Lung Neoplasms 11 Rectal Neoplasms 9 Nasopharyngeal Carcinoma 8 Colonic Neoplasms 7 Esophageal Neoplasms 6 Uterine Cervical Neoplasms 5 Pancreatic Neoplasms 5 Ovarian Neoplasms 5 Osteosarcoma 5 Brain Neoplasms 5 Small Cell Lung Carcinoma 4 Gastrointestinal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Precision Cell Immunotherapy 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Head and Neck Neoplasms 3 Gastrointestinal Diseases 3 Digestive System Neoplasms 3 Carcinoma, Hepatocellular 3 Biliary Tract Neoplasms 3 Solid Tumor 2

Interventions

Rituximab 51 Cyclophosphamide 36 Vincristine 24 Prednisone 23 Doxorubicin 21 Cytarabine 18 Etoposide 17 Lenalidomide 16 Gemcitabine 12 Melphalan 8 Filgrastim 8 Cisplatin 8 Peripheral Blood Stem Cell Transplantation 7 Oxaliplatin 7 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7 Ifosfamide 7 Carmustine 7 Methotrexate 6 zanubrutinib 5 Vindesine 5 Radiotherapy 5 R-CHOP protocol 5 Dexamethasone 5 Busulfan 5 ibrutinib 4 fludarabine phosphate 4 Methylprednisolone 4 Decitabine 4 Cyclosporine 4 Bendamustine Hydrochloride 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03383406 2017-12-26

IVAM

Asan Medical Center

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡